PATENT CLAIM ANALYSIS

Application Number: 16184903
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "597000"]

Abstract:
The present disclosure relates to the use of celiprolol or a pharmaceutically acceptable salt thereof for treating vascular Ehlers-Danlos syndrome in women during pregnancy and peripartum period.

Claim (Index 11):
The method of  claim 1 , wherein the method reduces the risk of death of the woman during the first year following termination of pregnancy.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13373145', '12453756', '13066914', '15129771', '14261057']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7540081816189221
- 35 USC 102 Novelty (BERT): 0.5236146948461907
- Combined Prediction Score: 0.730968832941649
- Mean Citation Score: 201.469168
- Max Citation Score: 211.40631
- Similarity Product: 98.674215655995

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test